Back to today’s briefing

Story perspectives

Revolutionary Weekly Pill Promises Breakthrough in Schizophrenia Treatment

6/12/2025

50 4

Summary

Story summary

Lyndra Therapeutics has unveiled a groundbreaking slow-release pill for schizophrenia, enabling patients to take risperidone just once a week instead of daily. This innovative approach enhances medication adherence, a major hurdle in treatment. Promising Phase III trial results, with only mild side effects, pave the way for future studies aimed at FDA approval, potentially revolutionizing schizophrenia care and minimizing clinic visits.

1 of 1

Story summary

Lyndra Therapeutics has unveiled a groundbreaking slow-release pill for schizophrenia, enabling patients to take risperidone just once a week instead of daily. This innovative approach enhances medication adherence, a major hurdle in treatment. Promising Phase III trial results, with only mild side effects, pave the way for future studies aimed at FDA approval, potentially revolutionizing schizophrenia care and minimizing clinic visits.